Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 410.90
-9.70 (-2.31%)
Sep 11, 2025, 5:24 PM IDT
Evogene Market Cap
Evogene has a market cap or net worth of 36.70 million as of September 12, 2025. Its market cap has decreased by -51.87% in one year.
Market Cap
36.70M
Enterprise Value
59.92M
Revenue
31.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
410.90
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 36.70M, a decrease of -67.57%. That is a compound annual growth rate of -6.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 36.08M | -23.82% |
| Dec 31, 2024 | 47.35M | -68.75% |
| Dec 31, 2023 | 151.55M | 64.52% |
| Dec 29, 2022 | 92.12M | -58.37% |
| Dec 30, 2021 | 221.26M | -59.72% |
| Dec 31, 2020 | 549.28M | 305.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.88B |
| Danel (Adir Yeoshua) | 2.89B |
| Kamada | 1.36B |
| BrainsWay | 990.45M |
| SofWave Medical | 980.61M |
| Bait Bakfar | 979.07M |
| Novolog (Pharm-Up 1966) | 757.12M |
| Ilex Medical | 708.32M |